The results come as Pfizer and other drugmakers grapple with Trump’s calls to lower U.S. drug prices and brace for his planned tariffs on pharmaceuticals.
Recent Posts
- Trump tariffs that are voided by — and ones that are safe from — Friday’s appeals court ruling
- CDC asks all staff to return to office Sept. 15, five weeks after shooting at headquarters
- ‘We shouldn’t ignore this:’ Longtime investor Rebecca Patterson warns Trump could damage Fed independence
- Here’s what it really means for Trump to get control of the Federal Reserve board
- I’m a personal finance reporter and I recently bought my wedding dress. Here’s what I wish I knew sooner